FAP Associated Papillary Thyroid Carcinoma: A Peculiar Subtype of Familial Nonmedullary Thyroid Cancer
暂无分享,去创建一个
[1] T. Hadjistilianou,et al. Next generation sequencing in sporadic retinoblastoma patients reveals somatic mosaicism , 2015, European Journal of Human Genetics.
[2] K. Dahan,et al. Evidence of digenic inheritance in Alport syndrome , 2015, Journal of Medical Genetics.
[3] P. Parrilla,et al. Familial nonmedullary thyroid cancer: screening, clinical, molecular and genetic findings. , 2014, Biochimica et biophysica acta.
[4] J. Guillem,et al. Results of a prospective thyroid ultrasound screening program in adenomatous polyposis patients. , 2014, American journal of surgery.
[5] T. Dragani,et al. Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients. , 2014, Lung cancer.
[6] J. Guillem,et al. The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized. , 2012, Clinical colorectal cancer.
[7] F. Cetta,et al. Familial Adenomatous Polyposis-Associated Papillary Thyroid Carcinoma Shows an Indolent Course and Usually, but Not Always, Belongs to the Cribriform-Morular Variant of Papillary Thyroid Carcinoma , 2012, Acta Cytologica.
[8] G. Ugolini,et al. FAP associated cribriform morular variant of PTC: striking female prevalence and indolent course. , 2011, Endocrine journal.
[9] J. Church,et al. Screening for Thyroid Cancer in Patients With Familial Adenomatous Polyposis , 2011, Annals of surgery.
[10] F. Cetta,et al. Comment on “Extra-Intestinal Manifestations of Familial Adenomatous Polyposis” , 2009, Annals of Surgical Oncology.
[11] F. Pacini,et al. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. , 2008, Endocrine-related cancer.
[12] L. Sobrinho,et al. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis. , 2008, The Journal of clinical endocrinology and metabolism.
[13] F. Cetta,et al. Inherited multitumoral syndromes including colorectal carcinoma. , 2007, Surgical oncology.
[14] F. Cetta,et al. Germ-line and Somatic Mutations of the APC Gene and/or ß Catenin Gene in the Occurrence of FAP Associated Thyroid Carcinoma , 2007, World Journal of Surgery.
[15] D. Chung,et al. Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[16] I. Bagwan,et al. Cribriform-morular variant of papillary carcinoma: The sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma , 2006 .
[17] R. Mariani-Costantini,et al. Mutations of APC and MYH in unrelated Italian patients with adenomatous polyposis coli , 2005, Human mutation.
[18] L. Thompson,et al. Papillary Thyroid Carcinoma , 2004, Ear, nose, & throat journal.
[19] A. Miyauchi,et al. Cribriform-morular variant of Papillary Thyroid Carcinoma: Clue to Early Detection of Familial Adenomatous Polyposis-associated Colon Cancer , 2004, World Journal of Surgery.
[20] G Riccabona,et al. Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer , 2004, Journal of Medical Genetics.
[21] M. Brandi,et al. Papillary thyroid carcinoma. , 2003, The American journal of surgical pathology.
[22] D. D. de Kretser,et al. Cribriform‐morular variant of papillary carcinoma: the sporadic counterpart of familial adenomatous polyposis‐associated thyroid carcinoma. A case report with clinical and molecular genetic correlation , 2003, Pathology.
[23] T. Sano,et al. Cribriform‐morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the β‐catenin gene , 2003, The Journal of pathology.
[24] M. Pelizzo,et al. Genetics and clinicopathological findings in thyroid carcinomas associated with familial adenomatous polyposis. , 1999, The American journal of pathology.
[25] J. Chan,et al. Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[26] N. Raffaelli,et al. The relationships between phenotypic expression in patients with familial adenomatous polyposis (FAP) and the site of mutations in the adenomatous polyposis coli (APC) gene. , 1999, Annals of surgery.
[27] A. Fusco,et al. Genetic Alterations in Thyroid Carcinoma Associated with Familial Adenomatous Polyposis: Clinical Implications and Suggestions for Early Detection , 1998, World Journal of Surgery.
[28] H. Gharib,et al. Thyroid Cancer in Patients with Familial Adenomatous Polyposis , 1998, World Journal of Surgery.
[29] G. Chiappetta,et al. The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas. , 1998, The Journal of clinical endocrinology and metabolism.
[30] F. Cetta. Familial nonmedullary thyroid carcinomas: a heterogeneous syndrome with different natural history and variable long-term prognosis. , 1997, The Journal of clinical endocrinology and metabolism.
[31] H. Harach. Age, sex and C cells: what about the human thyroid follicle with acid mucin and solid cell nests? , 1997, Journal of Clinical Endocrinology and Metabolism.
[32] P. Toti,et al. Thyroid carcinoma associated with familial adenomatous polyposis , 1997, Histopathology.
[33] F. Cetta,et al. Thyroid cancer and the Chernobyl accident. Are long-term and long distance side effects of fall-out radiation greater than estimated? , 1997, The Journal of clinical endocrinology and metabolism.
[34] J. Burgess,et al. Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. , 1997, The Journal of clinical endocrinology and metabolism.
[35] G. Williams,et al. Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm , 1994, Histopathology.
[36] H. Bussey,et al. Adenomatous polyposis: An association with carcinoma of the thyroid , 1987, The British journal of surgery.
[37] R. Stephenson. A and V , 1962, The British journal of ophthalmology.
[38] G. Ugolini,et al. Screening for thyroid cancer in patients with familial adenomatous polyposis. , 2015, Annals of Surgery.
[39] W. Marsden. I and J , 2012 .
[40] G. Chiappetta,et al. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. , 2002, The Journal of clinical endocrinology and metabolism.
[41] P. Battista,et al. Thyroid carcinoma usually occurs in patients with familial adenomatous polyposis in the absence of biallelic inactivation of the adenomatous polyposis coli gene. , 2001, The Journal of clinical endocrinology and metabolism.
[42] S. Olschwang,et al. Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. , 2000, The Journal of clinical endocrinology and metabolism.
[43] Z. Cohen,et al. Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study. , 1999, The American journal of pathology.
[44] D. Williams. Thyroid cancer and the Chernobyl accident. , 1996, The Journal of clinical endocrinology and metabolism.